Department of Pharmacology, Groupe de Recherche sur le Système Nerveux Central, Faculty of Medicine, Université de Montréal, Montréal, Québec H3C 3J7, Canada.
J Biol Chem. 2011 Jul 8;286(27):23928-37. doi: 10.1074/jbc.M111.218032. Epub 2011 May 16.
Somatodendritic (STD) dopamine (DA) release is a key mechanism for the autoregulatory control of DA release in the brain. However, its molecular mechanism remains undetermined. We tested the hypothesis that differential expression of synaptotagmin (Syt) isoforms explains some of the differential properties of terminal and STD DA release. Down-regulation of the dendritically expressed Syt4 and Syt7 severely reduced STD DA release, whereas terminal release required Syt1. Moreover, we found that although mobilization of intracellular Ca(2+) stores is inefficient, Ca(2+) influx through N- and P/Q-type voltage-gated channels is critical to trigger STD DA release. Our findings provide an explanation for the differential Ca(2+) requirement of terminal and STD DA release. In addition, we propose that not all sources of intracellular Ca(2+) are equally efficient to trigger this release mechanism. Our findings have implications for a better understanding of a fundamental cell biological process mediating transcellular signaling in a system critical for diseases such as Parkinson disease.
树突体(STD)多巴胺(DA)释放是大脑中 DA 释放的自动调节控制的关键机制。然而,其分子机制尚不确定。我们假设突触结合蛋白(Syt)异构体的差异表达解释了末端和 STD DA 释放的一些差异特性。树突表达的 Syt4 和 Syt7 的下调严重降低了 STD DA 的释放,而末端释放需要 Syt1。此外,我们发现尽管细胞内钙库的动员效率低下,但通过 N 和 P/Q 型电压门控通道的钙内流对于触发 STD DA 释放至关重要。我们的发现为末端和 STD DA 释放的不同钙需求提供了解释。此外,我们提出并非所有细胞内钙源都能同样有效地触发这种释放机制。我们的发现对于更好地理解在帕金森病等疾病关键系统中介导细胞间信号传递的基本细胞生物学过程具有重要意义。